Outpatient atrial fibrillation ablation: feasibility, safety and economic implications

17 April 2023 (12:00 - 13:00)

Organised by:

Abstract

Sign in to view the resources

Slides

About the speaker

Professor Javier Jimenez-Candil

IBSAL-Hospital Universitario de Salamanca, Salamanca (Spain)

9 More presentations in this session

Presentation thumbnail

How different very late recurrence of atrial fibrillation 5 years after catheter ablation?

Doctor S. Choi (Seoul, KR)

Abstract Slides

Presentation thumbnail

Progression and regression in the left atrial substrate in patients with atrial fibrillation: the PROGRESS-AF study

Doctor L. Marcon (Brussels, BE)

Abstract Slides

Presentation thumbnail

One-year outcomes in patients undergoing very high-power short-duration temperature-controlled ablation for atrial fibrillation

Doctor T. Strisciuglio (Naples, IT)

Abstract Slides

Presentation thumbnail

Insights into level of pulmonary vein isolation using pulsed-field ablation for atrial fibrillation and unexpected effects in the posterior wall.

Doctor J. Osca Asensi (Valencia, ES)

Abstract Slides

Presentation thumbnail

Patient perspectives on same-day discharge following catheter ablation for atrial fibrillation: results from the FAST AFA trial

Mr S. Koenig (Leipzig, DE)

Abstract Slides

Access the full session

Session thumbnail

Atrial Fibrillation - Round 5 - Ablation

The Event

Event poster

EHRA 2023

17 April 2023 12:00 CET

You may be interested in

Congress Presentation

One-year outcomes in patients undergoing very high-power short-duration temperature-controlled ablation for atrial fibrillation

Congress Presentation

An economic evaluation of first-line cryoballoon ablation versus antiarrhythmic drug therapy for the treatment of paroxysmal atrial fibrillation from an English NHS perspective

Congress Presentation

1-yr outcomes from the MANIFEST-PF registry

ESC 365 is supported by

novartis

Explore sponsored resources

ESC 365 is supported by

novartis

Explore sponsored resources